Analysts: Aurobindo Pharma Ltd (ARBN.NS)
171.30INR
24 May 2013
Rs-3.40 (-1.95%)
Rs174.70
Rs172.15
Rs175.80
Rs166.80
1,573,241
2,107,130
Rs204.90
Rs100.10
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -- | March | 25 May 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 9 | 9 | 8 | 8 |
| (2) OUTPERFORM | 6 | 7 | 6 | 5 |
| (3) HOLD | 3 | 2 | 4 | 4 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.67 | 1.61 | 1.78 | 1.76 |
Consensus Estimates Analysis
Earnings and Dividend Figures in India Rupee (INR)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Mar-13 | 16 | 56,867.30 | 59,012.00 | 51,871.60 | 52,746.60 |
| Year Ending Mar-14 | 16 | 66,279.50 | 74,430.00 | 59,555.30 | 61,173.90 |
| Earnings (per share) | |||||
| Year Ending Mar-13 | 17 | 14.43 | 16.40 | 11.10 | 15.20 |
| Year Ending Mar-14 | 17 | 20.72 | 30.60 | 14.00 | 20.07 |
| LT Growth Rate (%) | 1 | 20.00 | 20.00 | 20.00 | 10.90 |
Historical Surprises
Earnings and Dividend Figures in India Rupee (INR)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Dec-12 | 15,325.90 | 15,519.50 | 193.60 | 1.26 |
| Quarter Ending Sep-12 | 12,867.20 | 14,810.50 | 1,943.32 | 15.10 |
| Quarter Ending Jun-12 | 12,393.30 | 11,974.40 | 418.90 | 3.38 |
| Quarter Ending Mar-12 | 12,689.50 | 11,707.50 | 981.98 | 7.74 |
| Quarter Ending Dec-11 | 12,098.30 | 13,098.20 | 999.87 | 8.26 |
| Earnings (per share) | ||||
| Quarter Ending Dec-12 | 4.61 | 3.15 | 1.46 | 31.62 |
| Quarter Ending Sep-12 | 1.87 | 7.64 | 5.78 | 309.32 |
| Quarter Ending Jun-12 | 1.19 | -4.43 | 5.62 | 471.24 |
| Quarter Ending Mar-12 | 3.09 | 3.76 | 0.67 | 21.55 |
| Quarter Ending Dec-11 | 2.67 | -0.98 | 3.65 | 136.75 |
Consensus Estimates Trend
Earnings and Dividend Figures in India Rupee (INR)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Mar-13 | 56,867.30 | 56,867.30 | 56,867.30 | 56,613.00 | 52,746.60 |
| Year Ending Mar-14 | 66,279.50 | 66,279.50 | 66,279.50 | 65,856.80 | 61,173.90 |
| Earnings (per share) | |||||
| Quarter Ending Mar-13 | 14.43 | 14.43 | 14.43 | 14.11 | 15.20 |
| Quarter Ending Mar-14 | 20.72 | 20.72 | 20.72 | 20.46 | 20.07 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Year Ending Mar-13 | 0 | 0 | 0 | 0 |
| Year Ending Mar-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Year Ending Mar-13 | 0 | 0 | 0 | 0 |
| Year Ending Mar-14 | 0 | 0 | 0 | 0 |
Earnings vs. 
EstimatesAnalyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: News Bites Pty Limited
|
$5.00
|
|
Provider: News Bites Pty Limited
|
$5.00
|
|
Provider: News Bites Pty Limited
|
$5.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: News Bites Pty Limited
|
$5.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
